Leukemia Treatment Derived From Cord Blood Gains FDA Approval for Clinical Trials
A CAR-T cell therapy for acute lymphoblastic leukemia[1] has recently been approved by the FDA for use in clinical trials in the United States. The therapy is based on cells derived from allogeneic (donor) umbilical cord blood; it is the very first such treatment to...
Toddler’s Rare Leukemia Treated by Sister’s Cord Blood
After two planned transplants from unrelated donors fell through at the very last minute, Australian three-year-old Tommy Bacon is now in remission from a rare, dangerous form of leukemia following a transplant of the stem cells from his baby sister’s cord blood.[1]...
Gene Editing Stem Cell Therapy for Blood Disorder Begins NHS Rollout
Last week it was announced that a new gene editing stem cell therapy for beta thalassaemia would start to be made available on the UK’s National Health Service. As one of the first gene-editing therapies of its kind to be delivered through a national health...
World Sickle Cell Day and the Benefits of Cord Blood Banking
This year’s World Sickle Cell Day is on the 19th June, a day to recognize and raise awareness of the disease, the millions around the world who suffer from it, and ongoing research into how treatment is advancing. With this year’s theme being ‘we are STRONGER...
Recent Posts
-
Stem Cell Particles Used to Treat Severe Burns in a World First
-
Cord Blood Awareness Month 2026: The Past, Present, and Future of Cord Blood Stem Cells
-
Stem Cell Therapy for Alzheimer’s Granted FDA Fast Track as It Advances to Phase 2
-
Cord Tissue Stem Cells Enter a Trial for CTE – the Brain Injury Linked to Repeated Head Knocks
-
Stem Cell Anti-Ageing Trial Launches in China Using Cord Tissue Stem Cells
